“Splenic artery steal syndrome” is a misnomer: The cause is portal hyperperfusion, not arterial siphon
- 1 March 2008
- journal article
- case report
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (3) , 374-379
Abstract
Splenic artery embolization (SAE) improves hepatic artery (HA) flow in liver transplant (OLT) recipients with so‐called splenic artery steal syndrome. We propose that SAE actually improves HA flow by reducing the HA buffer response (HABR). Patient 1: On postoperative day (POD) 1, Doppler ultrasonography (US) showed patent vasculature with HA resistive index (RI) of 0.8. On POD 4, aminotransferases rose dramatically; his RI was 1.0 with no diastolic flow. Octreotide was begun, but on POD 5 US showed reverse diastolic HA flow with no signal in distal HA branches. After SAE, US showed markedly improved flow, RI was 0.6, diastolic flow in the main artery, and complete visualization of all distal branches. By POD 6, liver function had normalized. RI in the main HA is 0.76 at 2 months postsurgery. Patient 2: On POD 1, RI was 1.0. US showed worsening intrahepatic signal, with no signal in the intrahepatic branches and reversed diastolic flow despite good graft function. On POD 7, SAE improved the intrahepatic waveform and RI (from 1.0 to 0.72). Patient 3: Intraoperative reverse diastolic arterial flow persisted on PODs 1, 2, and 3, with progressive loss of US signal in peripheral HA branches. SAE on POD 4 improved the RI (0.86) and peripheral arterial branch signals. Patient 4: US on POD 1 showed good HA flow with a normal RI (0.7). A sudden waveform change on POD 2 with increasing RI (0.83) prompted SAE, after which the wave form normalized, with reconstitution of a normal diastolic flow (RI 0.68). In conclusion, these reports confirm the usefulness of SAE for poor HA flow but suggest that inflow steal was not the problem. Rather than producing an increase in arterial inflow, SAE worked by reducing portal flow and HABR, thereby reducing end‐organ outflow resistance. Evidence of this effect is the marked reduction of the RI after the SAE to 0.6, 0.72, 0.86, and 0.68, in patients 1‐4, respectively. SAE reduces excessive portal vein flow and thereby ameliorates an overactive HABR that can cause graft dysfunction and ultimately HA thrombosis. Liver Transpl 14:374–379, 2008. © 2008 AASLD.Keywords
This publication has 11 references indexed in Scilit:
- Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size SyndromeAmerican Journal of Surgical Pathology, 2006
- Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantationTransplant International, 2005
- Effects of Hemi-Portocaval Shunts For Inflow Modulation on the Outcome of Small-for-Size Grafts in Living Donor Liver TransplantationAmerican Journal of Transplantation, 2005
- Diagnosis and treatment of arterial steal syndromes in liver transplant recipientsLiver Transplantation, 2003
- Small-for-size partial liver graft in an adult recipient; a new transplant techniqueThe Lancet, 2002
- Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPSAmerican Journal of Gastroenterology, 2001
- THE INTERRELATIONSHIP BETWEEN PORTAL AND ARTERIAL BLOOD FLOW AFTER ADULT TO ADULT LIVING DONOR LIVER TRANSPLANTATIONTransplantation, 2000
- Octreotide Compared With Placebo in A Treatment Strategy for Early Rebleeding in Cirrhosis. A Double Blind, Randomized Pragmatic TrialHepatology, 1998
- The prediction of portal pressure: A multivariate analysis of clinical data and intraoperative portal pressureSurgery Today, 1994
- Arterial steal: an unusual cause for hepatic hypoperfusion after liver transplantationTransplant International, 1991